Discontinued — last reported Q4 '25
Aon plc Acquisitions increased by 150.8% to $296.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 155.2%, from $116.00M to $296.00M. Over 4 years (FY 2021 to FY 2025), Acquisitions shows an upward trend with a 130.3% CAGR.
High spending indicates an aggressive growth strategy, while low spending may indicate a focus on organic growth or debt reduction.
This represents the net cash outflow for the purchase of other businesses or strategic assets, adjusted for any cash acq...
Highly variable; pharmaceutical companies frequently use M&A to offset patent cliffs and expand therapeutic portfolios.
acquisitions| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $3.00M | $11.00M | $134.00M | $9.00M | $11.00M | $8.00M | $2.00M | $6.00M | $10.00M | $17.00M | $4.00M | $2.78B | $231.00M | $495.00M | $116.00M | $27.00M | $133.00M | $118.00M | $296.00M |
| QoQ Change | — | — | +266.7% | >999% | -93.3% | +22.2% | -27.3% | -75.0% | +200.0% | +66.7% | +70.0% | -76.5% | >999% | -91.7% | +114.3% | -76.6% | -76.7% | +392.6% | -11.3% | +150.8% |
| YoY Change | — | — | — | — | — | +266.7% | -27.3% | -98.5% | -33.3% | -9.1% | +112.5% | +100.0% | >999% | >999% | >999% | >999% | -99.0% | -42.4% | -76.2% | +155.2% |